These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 6216848

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies.
    Berrih S, Gaud C, Bach MA, Le Brigand H, Binet JP, Bach JF.
    Clin Exp Immunol; 1981 Jul; 45(1):1-8. PubMed ID: 6458432
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [T suppressor cell function in patients with myasthenia gravis].
    Hu Q.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):136-9, 188. PubMed ID: 2143975
    [Abstract] [Full Text] [Related]

  • 5. [Mononuclear cell subsets in the peripheral blood of patients with myasthenia gravis].
    Bu B.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):140-2, 188-9. PubMed ID: 1975232
    [Abstract] [Full Text] [Related]

  • 6. Suppressor T cells in myasthenia gravis and antibodies to acetylcholine receptor.
    Lisak RP, Laramore C, Levinson AI, Zweiman B, Moskovitz AR.
    Ann Neurol; 1986 Jan; 19(1):87-9. PubMed ID: 2936299
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
    Ofosu-Appiah W, Mokhtarian F, Shirazian D, Grob D.
    J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical implications of the type 1/type 2 balance of helper T cells and P-glycoprotein function in peripheral T lymphocytes of myasthenia gravis patients.
    Masuda M, Tanaka S, Nakajima K, Yamada N, Ido N, Ohtsuka T, Nishida M, Hirano T, Utsumi H.
    Eur J Pharmacol; 2010 Feb 10; 627(1-3):325-31. PubMed ID: 19863946
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunosuppressive therapy of myasthenia gravis.
    Szobor A, Petrányi G.
    Acta Med Acad Sci Hung; 1970 Feb 10; 27(4):397-411. PubMed ID: 5314027
    [No Abstract] [Full Text] [Related]

  • 14. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ, Olanow CW, Dawson DV, Crane B, Roses AD.
    J Immunol; 1984 Mar 10; 132(3):1229-36. PubMed ID: 6229579
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Idiotype- and anti-idiotype-reactive T lymphocytes in myasthenia gravis. Evidence for the involvement of different subpopulations of T helper lymphocytes.
    Yi Q, Lefvert AK.
    J Immunol; 1994 Oct 01; 153(7):3353-9. PubMed ID: 8089503
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppressive therapies in myasthenia gravis.
    Sanders DB, Evoli A.
    Autoimmunity; 2010 Aug 01; 43(5-6):428-35. PubMed ID: 20166870
    [Abstract] [Full Text] [Related]

  • 19. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.
    Fattorossi A, Battaglia A, Buzzonetti A, Ciaraffa F, Scambia G, Evoli A.
    Immunology; 2005 Sep 01; 116(1):134-41. PubMed ID: 16108825
    [Abstract] [Full Text] [Related]

  • 20. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
    Zhang J, Zhou WB, Wang HL, Guo SS.
    Hum Antibodies; 1997 Sep 01; 8(2):90-4. PubMed ID: 9289393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.